Emergency Call- 24/7 support
Home » Healthcare » Advanced Technologies » HAD-4111116
* For discount/customization and buying a particular chapter click here or write to us at [email protected]
Cell cultures are essential tools that are used in a wide range of clinical in vitro research studies. 3D cell culture provides an artificial environment which permit biological cells to grow in three dimensions to provide better result than 2D cell culture which is grown in petri dish. Ongoing trend in the development of novel therapies that are more effective, reliable, and safe is prevailing in 3D cell culture market. The global 3D cell culture market is expected to grow with a CAGR of 23.7% during 2016-2023.
The 3D cells cultures are usually grown in a small capsule or bioreactor in which the cell can grow in any shape 3D or spheroid. 3D culture exhibit a higher degree of structural complexity a homeostasis which is analogous to tissues and organs. Advantages of 3D cell culture are proximity of other cells on all side behavior similar to invivo condition and more accurate representation of cyto architecture. These type of culture can also be used as stimulators of tumor characteristic such as hypoxia, anti-apoptotic and dormancy. From past several years tremendous efforts has been put in development of as well as use of 3D cell culture in stem cells study, drug discovery, tissue implantation cancer study etc. 3D cell culture is widely used in research labs, hospitals, and pharmaceutical, biopharmaceutical & biotechnology firm and their use is expected to increase in forecast period. Cell biologics, and increasing incident of various chronic diseases such as hepatitis, HIV, cancer etc. are expected to drive 3D cell culture market. New innovations in tissue engineering and 3D printing technology have increased organ harvesting and transplant. Cell based therapies in hospitals and diagnostic centers for oncology patient are set to propel 3D cell culture market for the forecast period. Increasing cell based research, new innovations in cell culture, technological advancements in cell biology research and rising funding for research related activities are some drivers for the market. High investments for cell biology research and shortage of infrastructure for cell based research in emerging countries are few restraints hindering the market growth while factors such as growing demand for organ transplant and increasing R&D investments providing opportunities in forecast period.
Source: OBRC Analysis
The global 3D cell culture market is segmented into technology, applications and end users. Technology segmented, is further sub segmented into:
Application segment is sub segmented into:
In vivo applications of stem cells:
End user segment is classified into:
The revenue for the above application and end-user segment are specific to the 3D cell culture market. However, the total revenue of these application and end-users in general has been excluded from the scope of the report.
Geographically, the global 3D cell culture market has been segmented on the basis of four major region, which include:
North America is accounted for the largest share of 3D cell culture market and dominating 3d cell culture market. North American markets are driven by demand for organ transplants and increasing demand of research especially in oncology, favorable regulatory environment and increase in expenditure for healthcare sector are also driving North America 3D cell culture market. Europe is the second largest region in 3D cell culture market. Increasing research towards cell biology, biotechnology and oncology both at university and industrial levels are driving the growth of 3D Cell Culture market in Europe, for the forecast period. UK and Germany are the leading market in Europe for 3D cell culture with increasing investments for cancer research.
Asia Pacific is the fastest growing market for 3D cell culture market. Increasing government investment in the area of cell biology and oncology research, growing talent pool towards cell biology research, and new regulatory reforms are the driving force behind 3D Cell culture market in Asia Pacific. China and India are the leading markets in Asia Pacific, with growing awareness of organ transplantation and increasing investment cancer research being the driving factors. Medical tourism is also a factor in growth of 3d cell culture market in APAC.
The research report is segmented in terms of technology, applications, and end users. Technology segmented, is further sub segmented into with scaffold and without scaffold. Without scaffold technology segment is divided further into 3D bioreactors, 3D petri-dishes, 3D bio-printing, microfluidics and hanging drop plates. With scaffold technology segments is classified into solid structure scaffold, hydrogels/ECM and micro-patterned surfaces. Scaffold-based 3D cell culture products is expected to dominate due to its ability to mimic in vivo conditions. Application segment is sub segmented into tissue engineering, cell based assay, oncology, in vivo applications of stem cells, 3D printing, and other applications. Cancer and stem cell research segment is projected to grow with highest CAGR due to increasing incidences of cancer and significant funding initiatives for cancan research. End user segment is classified into biotechnology and pharmaceutical industries, research laboratories, hospitals and diagnostic centers, and other end users. Biotechnology and pharmaceutical industries are the leading end user segment for 3D cell culture market for the forecast period.
The major market players of the global 3D cell culture market are:
Detailed analysis of these companies provided in this report comprises Overview, SCOT Analysis, Product Portfolio, Strategic Initiative and Strategic Analysis.
These companies using various strategies such as merger & acquisition, collaboration, partnership and product launching. Example Pluristem Therapeutics on 15th April 2016 was granted patent by Japan Patent Office on 3D cell culture method for cell based therapies from placental cells against hematopoietic diseases caused by chemotherapy or failed transplants. Also, Lonza Group Ltd. signed an agreement with TAP Biosystems on July 2015 to distribute the companies’ 3D cell culture system. Moreover, in 2016, Thermo fisher acquired MTI-Globalstem to bolster its stem cell technology and reagent business.
Why to buy the report:
This report will:
How we are different from others:
At Occam’s we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global 3D cell culture market offers the longest chain of market segmentation covering major market segmentation based on products, application and end users. The report tracks the major market trends in the global 3D cell culture market such as technological advancement, funding initiatives from government and so on. For each market segments covered in global 3D cell culture market report, we provide opportunity matrix, and DRO analysis, that enable the clear growth assessment across each market segment. The report discusses competitive landscape of the 3D cell culture industry, with giving extensive strategy analysis of more than 15 companies. Moreover, the report discusses various models such as 360 degree analysis, See Saw analysis, and Porter five force model and so on. For the high level analysis in the report we provide a comparative analysis of historic and current year data.
Key Findings of the global 3D cell culture market: